Gretel and Illumina Partner to Develop Synthetic Data for Genomic Research

SAN DIEGO–(BUSINESS WIRE)– #privacyengineering–Today, announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, to create privacy-protected, synthetic genomic data that can be accessed by medical researchers anywhere. This announcement includes the release of a successful study the partnership conducted, which proves the viability of significant new use cases for synthetic data in genomics and related fields including medical diagnosi
Click here to view original post

ADVERTISEMENT — Advertise With Biotech Networks